Respiratory Infections News

Unsurprisingly, many of our most-read stories in 2021 were about the COVID-19 pandemic. Stories about COVID-19 vaccines and therapeutics were popular, especially those dealing with approvals, authorizations or recommendations.

In updated guidance, the CDC said that asymptomatic people with COVID-19 can isolate for 5 days instead of 10, followed by 5 days of wearing a mask around other people.

The American Thoracic Society published a new clinical practice guideline to aid physicians in the outpatient management of infants, children and adolescents with post-prematurity respiratory disease.

An early 3-day course of remdesivir lowered the risk for hospitalization or death among nonhospitalized patients at high risk for severe COVID-19 by 87%, according to a study published in The New England Journal of Medicine.

For years, we have been asking you to tell us why you chose a career in infectious diseases, a specialty whose importance has hardly been more apparent. We continue to be captivated by the stories you tell.

We compiled a list of the 10 most-read Healio | Infectious Disease News articles from 2021.

The FDA has issued an emergency use authorization for molnupiravir — now the second oral antiviral treatment available for COVID-19.

A COVID-19 vaccine for young children is “unlikely” to be available before mid or even late 2022, an expert said.

Patients with severe COVID-19 had more than twice the risk for mortality within 12 months of diagnosis compared with those who had mild or moderate disease or were not infected, data showed.

The FDA on Wednesday issued an emergency use authorization for Pfizer’s Paxlovid, making it the first available oral antiviral treatment for COVID-19.